[1]樊红,冯彦虎,张德奎△,等.中西医结合治疗肝炎后肝硬化腹水疗效观察[J].西部中医药,2013,26(02):91-93.
　FAN Hong,FENG Yanhu,ZHANG Dekui,et al.Clinical Observation on Integrative Medicine in Treating Cirrhosis Ascites of Patients with Hepatitis[J].Western Journal of Traditional Chinese Medicine,2013,26(02):91-93.
点击复制

中西医结合治疗肝炎后肝硬化腹水疗效观察
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
26
期数:
2013年02期
页码:
91-93
栏目:
出版日期:
2013-02-15

文章信息/Info

Title:
Clinical Observation on Integrative Medicine in Treating Cirrhosis Ascites of Patients with Hepatitis
文章编号:
1004-6852(2013)02-0091-03
作者:
樊红，冯彦虎，张德奎△，王祥
兰州大学第二医院消化科，甘肃 兰州 730030
Author(s):
FAN Hong, FENG Yanhu, ZHANG Dekui△, WANG Xiang
Gastroenterology Department of Lanzhou University Second Hospital, Lanzhou 730030, China
关键词:
肝硬化; 肝炎后; 中西医结合; 治疗; 临床有效性
Keywords:
cirrhosis;  induced by hepatitis;  integrative medicine;  treatment;  clinical validity
分类号:
R256
文献标志码:
B
摘要:
目的：观察中西医结合治疗肝炎后肝硬化腹水的临床疗效。方法：选择肝炎后肝硬化患者共54例，采用随机数字表法分为中西医结合治疗组29例与西药对照组25例，1个疗程28天，治疗6个疗程后比较2组临床疗效。结果：中西医结合治疗组总有效率为93.10%，优于西药对照组的84.00%，两者相比差异有统计学意义（P＜0.05），中西医结合治疗组肝功能改善优于西药对照组。结论：中西医结合治疗肝炎后肝硬化较 西药对照组疗效好，且安全、无明显毒副作用。
Abstract:
Objective: To observe clinical effects of integrative medicine in treating cirrhosis ascites of patients with hepatitis. Method: All 54 patients were chosen and separated into 29 cases in the treatment group of integrative medicine and 25 cases in the control group of western medicine with the method of random number table. One course of treatment was 28 days and clinical effects of both groups were compared after six consecutive courses of treatment. Result: Total effective rate of the treatment group of integrative medicine was 93.10%, superior to 84.00% of the control group of western medicine with statistical meaning (P＜0.05). Conclusion: Integrative medicine is more effective than western medicine in treating cirrhosis of hepatitis, it is safe without remarkable toxicity.

参考文献/References:

［1］ 中华医学会肝病学分会，中华医学会感染病学分会.慢性乙型肝炎防治指南［J］.中华内科杂志，2006，45(2):162-170. ［2］ 郑筱萸.中药新药临床研究指导原则［M］.北京:中国医药科技出版社，2007：143-151. ［3］ 黄思敏，杨冬华.早期肝硬化的临床诊断与治疗现状［J］.广东医学，2006，27(2):287-289. ［4］ 北京中医医院.关幼波临床经验选［M］.北京:人民卫生出版社，2010:155. ［5］ 唐国廷.黄芪药理作用与临床应用研究进展［J］.中医药临床杂志，2010，22(9):844. ［6］ 杨竹芳，陈利霞，孟卉秦.丹参注射液治疗急性黄疸型肝炎疗效分析［J］.吉林医学，2012，33(18):3869.

相似文献/References:

[1]黄鸿娜,黄晶晶△,王振常,等.柔肝化纤颗粒治疗肝硬化脾功能亢进症的临床观察[J].西部中医药,2014,27(09):111.
[2]张萍,朱建坤.肝硬化患者应用中医食疗的临床护理分析[J].西部中医药,2013,26(07):112.
　ZHANG Ping,ZHU Jiankun.Analysis on Clinical Nursing for Liver Cirrhosis Patients Given with TCM Food Therapy[J].Western Journal of Traditional Chinese Medicine,2013,26(02):112.
[3]刘建军,曾贤翠,郝淑萍,等.腹水超滤浓缩回输联合中医辨证治疗肝硬化顽固性腹水40例临床观察[J].西部中医药,2013,26(06):1.
　LIUJianjun,ZENGXiancui,HAOShuping,et al.ClinicalObservationonUltrafiltrationReinfusionofConcentratedAscitesandSyndromeDifferentiationforRefractoryAscitesofLiverCirrhosis:AReportof40Cases[J].Western Journal of Traditional Chinese Medicine,2013,26(02):1.
[4]闫雪华.恩替卡韦联合复方鳖甲软肝片治疗代偿期乙肝肝硬化疗效观察[J].西部中医药,2014,27(07):84.
　YAN Xuehua.Clinical Observation on Entecavir Combined with Compound BieJia RuanGan Tablets in Treating Decompensated Liver Cirrhosis of Hepatitis B[J].Western Journal of Traditional Chinese Medicine,2014,27(02):84.
[5]龚红霞,邱晶.多层螺旋CT门静脉成像在肝硬化中医证型诊断中的应用价值[J].西部中医药,2018,31(12):147.
　GONG Hongxia,QIU Jing.Application Value of Multilayer Spiral CT Portal Vein Imaging in the Diagnosis of TCM Patterns of Liver Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2018,31(02):147.
[6]朱艳国,朱艳丽△,张金花.自拟化积膏治疗肝硬化疗效观察[J].西部中医药,2019,32(05):63.
　ZHU Yanguo,ZHU Yanli,ZHANG Jinhua.Clinical Observation on Selfmade HuaJi Ointment in Treating Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2019,32(02):63.
[7]陈美岑,等.柔肝化纤颗粒对失代偿期肝硬化患者肠道菌群的影响[J].西部中医药,2021,34(12):99.[doi:10.12174/j.issn.2096-9600.2021.12.26]
　CHEN Meicen,WANG Zhenchang,et al.Effects of Rougan Huaxian Granules on Intestinal Flora in Patients with Decompensated Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2021,34(02):99.[doi:10.12174/j.issn.2096-9600.2021.12.26]
[8]徐婷婷,安振涛,李慧,等.肝硬化腹水证治分布及脐敷疗法用药规律文献研究[J].西部中医药,2021,34(06):85.[doi:10.12174/j.issn.2096-9600.2021.06.20]
　XU Tingting,AN Zhentao,LI Hui,et al.Literature Study on the Distribution of Syndrome Differentiation and Treatment of Cirrhosis Ascites and Medication Rules of Umbilical Compressing Therapy[J].Western Journal of Traditional Chinese Medicine,2021,34(02):85.[doi:10.12174/j.issn.2096-9600.2021.06.20]
[9]马玉珍,毛德文,覃艳新,等.六味醒神颗粒治疗肝硬化轻微型肝性脑病的临床疗效及其对血氨和内毒素的影响[J].西部中医药,2021,34(05):7.[doi:10.12174/j.issn.2096-9600.2021.05.03]
　MA Yuzhen,MAO Dewen,QIN Yanxin,et al.Clinical Effects of Liuwei Xingshen Granules in Treating Mild Hepatic Encephalopathy of Liver Cirrhosis and Its Influence on Blood Ammonia and Endotoxin[J].Western Journal of Traditional Chinese Medicine,2021,34(02):7.[doi:10.12174/j.issn.2096-9600.2021.05.03]
[10]吴铁雄,刘旭东,朱沪敏,等.大黄?虫胶囊联合心得安治疗乙肝肝硬化门脉高压症临床观察[J].西部中医药,2023,36(02):102.[doi:10.12174/j.issn.2096-9600.2023.02.23]
　WU Tiexiong,LIU Xudong,ZHU Humin,et al.Clinical Observation on Dahuang Zhechong Capsules and Propranolol in the Treatment of Portal Hypertension of Hepatitis B Cirrhosis[J].Western Journal of Traditional Chinese Medicine,2023,36(02):102.[doi:10.12174/j.issn.2096-9600.2023.02.23]

备注/Memo

备注/Memo:
收稿日期：2012-08-16 作者简介：樊红(1963—)，女，副主任医师。研究方向：消化系统疾病的诊治。 △通讯作者：张德奎(1972—)，男，博士学位，硕士研究生导师，主任医师，副教授。研究方向：消化道肿瘤与炎症性肠病的诊治。
更新日期/Last Update: 2013-02-15